Article info
Original research
Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa
- Correspondence to Dr Jaime Cordero-Ramos, Pharmacy Unit, Hospital Universitario Virgen Macarena, Sevilla, Spain; corderojaime7{at}gmail.com
Citation
Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa
Publication history
- Received September 25, 2020
- Revised November 19, 2020
- Accepted December 1, 2020
- First published December 16, 2020.
Online issue publication
October 18, 2023
Article Versions
- Previous version (14 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ.